[link|183|Daiichi Sankyo website] is a pharmaceutical company with headquarters in Tokyo. Daiichi Sankyo is a merger of Sankyo Co. and Daiichi Pharmaceutical Co., finalized in 2007. The focus is on R and D, manufacturing, import, and sales/marketing of pharmaceutical products. Sales of Daiichi Sankyo are in the order of 950 billion Yen (~ 8,5 billion €). Daiichi Sankyo has ~ 30.000 employees. Capital is 50 billion yen (~ 450 million €). Chairman is Mr Takashi SHODA, CEO is Mr Yoji NAKAYAMA.